Most Oncologists Feel New Genetic Test for Tamoxifen Sensitivity Not Ready for the Clinic

Friday, December 11, 2009 - 15:14 in Health & Medicine

(PhysOrg.com) -- Despite commercial availability and direct to consumer marketing of a new genetic test designed to reveal a breast cancer patient`s sensitivity to tamoxifen, most physicians in the U.S. are not currently using it to guide treatment, according to research from Duke University Medical Center presented today at the CTRC-AACR San Antonio Breast Cancer Symposium.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net